GHRS GH Research PLC

Price (delayed)

$23.24

Market cap

$1.44B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.92

Enterprise value

$1.2B

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 5

gh research is a privately-held clinical-stage biopharmaceutical company developing novel therapies for the management of mental illness.

Highlights
GH Research's debt has decreased by 34% YoY and by 16% QoQ
GH Research's net income has decreased by 34% YoY and by 17% from the previous quarter
The quick ratio fell by 32% QoQ and by 23% YoY

Key stats

What are the main financial stats of GHRS

GHRS stock price

How has the GH Research stock price performed over time
Intraday
-4.87%
1 week
3.84%
1 month
7.15%
1 year
86.97%
YTD
82.99%
QTD
65.29%

Financial performance

How have GH Research's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$66.74M
Net income
-$56.41M
Gross margin
N/A
Net margin
N/A
GH Research's net income has decreased by 34% YoY and by 17% from the previous quarter
GH Research's operating income has decreased by 30% YoY and by 10% from the previous quarter

Price vs fundamentals

How does GHRS's price correlate with its fundamentals

Growth

What is GH Research's growth rate over time

Valuation

What is GH Research stock price valuation
P/E
N/A
P/B
5.47
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GHRS's EPS is down by 16% since the previous quarter and by 16% year-on-year
The price to book (P/B) is 113% more than the 5-year quarterly average of 2.7 and 98% more than the last 4 quarters average of 2.9
GH Research's equity has decreased by 15% YoY and by 6% QoQ

Efficiency

How efficient is GH Research business performance
GHRS's return on invested capital has dropped by 53% since the previous quarter
GHRS's return on equity is down by 21% since the previous quarter and by 3.1% year-on-year
The return on assets has declined by 21% since the previous quarter and by 3.8% year-on-year

Dividends

What is GHRS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GHRS.

Financial health

How did GH Research financials performed over time
GHRS's total liabilities is up by 39% from the previous quarter and by 16% YoY
GHRS's current ratio is down by 32% since the previous quarter and by 22% year-on-year
GH Research's debt is 100% lower than its equity
GH Research's debt has decreased by 34% YoY and by 16% QoQ
GH Research's equity has decreased by 15% YoY and by 6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.